Related Articles
Downregulation of HNF1 homeobox B is associated with drug resistance in ovarian cancer
Upregulation of NEK2 is associated with drug resistance in ovarian cancer
Downregulation of tumor suppressor gene ribonuclease T2 and gametogenetin binding protein 2 is associated with drug resistance in ovarian cancer
Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance
Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer